Showing 1591-1600 of 1635 results for "".
- Sue Anschutz-Rodgers Eye Center: A Highly Visible Legacy of Longstanding Philanthropic Partnershiphttps://modernod.com/news/sue-anschutz-rodgers-eye-center-a-highly-visible-legacy-of-longstanding-philanthropic-partnership/2480040/The University of Colorado Anschutz Medical Campus and UCHealth announced the naming of the UCHealth Eye Center program for philanthropist Sue Anschutz-Rodgers, who has made leadership gifts to accelerate innovative r
- Study: Combined Cataract Surgery Ups Postop Endophthalmitis Riskhttps://modernod.com/news/study-combined-cataract-surgery-ups-postop-endophthalmitis-risk/2480042/Patients who undergo combined cataract surgery, or removal of cataracts combined with treatment of other eye disorders during the same procedure, have higher incidence of acute postoperative endophthalmitis (acute POE) compared with those who have cataract surgery alone, results of a French natio
- Oyster Point Pharma Gets Green Light From FDA to Proceed With Clinical Development of Dry Eye Treatmenthttps://modernod.com/news/oyster-point-pharma-gets-green-light-from-fda-to-proceed-with-clinical-development-of-dry-eye-treatment/2480060/Oyster Point Pharma announced that the FDA has cleared the company’s investigational new drug (IND) application to proceed with clinical development of OC-01, an investigational compound intended to stimulate natural tear film production in people with dry eye disease that is administered with a
- Neuro-Optometric Rehabilitation Association (NORA) Launches Redesigned Website; Accepts Award Nominationshttps://modernod.com/news/neuro-optometric-rehabilitation-association-nora-launches-redesigned-website-accepts-award-nominations/2480061/The Neuro-Optometric Rehabilitation Association, International (NORA) announced the launch of its redesigned website and new domain name, www.noravisionrehab.org, dedicated to educating patients, caregivers, and health care professionals about neurolog
- American Vision Partners Acquires Miles Eye Centerhttps://modernod.com/news/american-vision-partners-acquires-miles-eye-center/2480084/Private Equity-backed American Vision Partners announced a partnership between one of its affiliates, Barnet Dulaney Perkins Eye Center, and Miles Eye Center. Under the name of Barnet Dulaney Perkins Eye Center, patients at Mi
- American Academy of Ophthalmology Reiterates Long-Standing Guidance on LASIK Patient Educationhttps://modernod.com/news/american-academy-of-ophthalmology-reiterates-long-standing-guidance-on-lasik-patient-education/2480085/The American Academy of Ophthalmology reiterated its long-standing guidance for patients considering LASIK vision correction surgery. The possible complications from this elective procedure have long been known but have nevertheless garnered recent attention in the national media. &
- Shire Launches “Screen Responsibly” Initiative to Prioritize Eye Health in a Screen-Saturated Worldhttps://modernod.com/news/shire-launches-screen-responsibly-initiative-to-prioritize-eye-health-in-a-screen-saturated-world/2480096/Shire announced the launch of “Screen Responsibly,” a new educational initiative about the intersection between screen use and eye health. This initiative is underscored by new national Shire-sponsored survey data and as part of it, a partnership with Thrive Global, a behavior-change
- Novartis CEO Says Drugmaker’s Deal With Trump Lawyer Was a “Mistake”https://modernod.com/news/novartis-ceo-says-drugmakers-deal-with-trump-lawyer-was-a-mistake/2480155/In an internal email sent to employees, Novartis CEO Vasant Narasimhan apologized for the $1.2-million agreement the company made with President Donald Trump’s private lawyer Michael Cohen early last year in a bid to gain insight into US healthcare policy under the new administration. <
- LayerBio Awarded $1.2 Million from NIH to Develop Sustained-Release Glaucoma Drughttps://modernod.com/news/layerbio-awarded-1-2-million-from-nih-to-develop-sustained-release-glaucoma-drug/2480164/Founded in 2013 as a spin-off from the lab of Dr. Paula Hammond at MIT, LayerBio is developing novel drug delivery products for ophthalmology, wound care, tendon repair and other unmet medical needs. The National Eye Institute at the National I
- Valeant Will Become Bausch Health Companieshttps://modernod.com/news/valeant-will-become-bausch-health-companies-inc/2480165/Valeant Pharmaceuticals International announced that the company will change its name to Bausch Health Companies beginning in July 2018. “Becoming Bausch Health Companies is a major step forward in our transformation,” Joseph C. Papa, chairman and CEO, Valeant, said in a compan